Get the Stockscreener App
4.52
4.87%
0.21
After Hours:
4.53
0.01
+0.22%
Briacell Therapeutics Corp stock is traded at $4.52, with a volume of 219.28K.
It is up +4.87% in the last 24 hours and up +9.44% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$4.31
Open:
$4.23
24h Volume:
219.28K
Relative Volume:
0.49
Market Cap:
$32.77M
Revenue:
-
Net Income/Loss:
$-29.96M
P/E Ratio:
-0.1636
EPS:
-27.6253
Net Cash Flow:
$-31.64M
1W Performance:
+5.12%
1M Performance:
+9.44%
6M Performance:
-50.60%
1Y Performance:
+5.85%
1-Day Range:
$4.21
$4.55
1-Week Range:
$4.062
$4.60
52-Week Range:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.52 | 31.25M | 0 | -29.96M | -31.64M | -27.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Aug Outlook: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeti - GuruFocus
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR - TipRanks
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference - Bitget
BriaCell to Present Positive Clinical Data for Bria-IMT™ - GlobeNewswire
(BCT) Strategic Investment Guide (BCT:CA) - Stock Traders Daily
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Why did BCTX stock surge 50% today? - MSN
BriaCell (NASDAQ: BCTX) boosts cash to fund cancer trials amid higher losses - Stock Titan
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - Yahoo Finance
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
BriaCell (NASDAQ: BCTX) shareholders re-approve equity plan and board slate - Stock Titan
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Merger Talk: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Volume Report & Weekly Momentum Stock Picks - baoquankhu1.vn
How To Trade (BCT) (BCT:CA) - Stock Traders Daily
Retail Trends: Does BriaCell Therapeutics Corp align with a passive investing strategy2025 Market Sentiment & Growth-Oriented Investment Plans - baoquankhu1.vn
BCT.CA Earnings History & Surprises | EPS & Revenue Results | BRIACELL THERAPEUTICS CORP (TSX:BCT) - ChartMill
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - Investing News Network
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting - TipRanks
Aug Retail: Can BriaCell Therapeutics Corp ride the EV waveEntry Point & Smart Money Movement Alerts - baoquankhu1.vn
AI Stocks: Is Putnam Master Intermediate Income Trust stock risky to hold nowMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
BriaCell Therapeutics: Key Catalysts on the Horizon for Investors - AD HOC NEWS
Trading (BCT) With Integrated Risk Controls (BCT:CA) - Stock Traders Daily
EPS Watch: Is BriaCell Therapeutics Corp a defensive stockEarnings Risk Summary & Smart Investment Allocation Tips - baoquankhu1.vn
BCTXZBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
BCTXBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Basic earnings per share (basic EPS) of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to earnings ratio of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Number of employees of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BCTXL | BriaCell Therapeutics Corp. Warrant Institutional Ownership - Quiver Quantitative
BCTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCTXW SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Net income of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BriaCell Therapeutics (BCTX) files Form 25 to remove Warrants from Nasdaq - Stock Titan
BCTXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Street Watch: Is BriaCell Therapeutics Corp a defensive stock2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - National Today
BCTXZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BriaCell spins off sCD80 cancer therapy to BriaPro in strategic deal - Indian Pharma Post
BriaCell Restructures Soluble CD80 Program via BriaPro Deal - TipRanks
BriaCell enters asset sale to BriaPro for sCD80, receives 23.97M shares and up to $3M credit - TradingView
(BCT) Investment Performance Report (BCT:CA)Stock Traders Daily Canada - Stock Traders Daily
Is BriaCell Therapeutics Corp. stock a top pick in earnings seasonJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - mfd.ru
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):